Aspen Surgical Products Inc. has acquired the blades and scalpels business of Becton, Dickinson and Co. for an undisclosed sum.
Aspen’s acquisition of BD’s Bard-Parker business beefs up its line of products for operating room use, according to a statement from RoundTable HealthCare Partners, the Illinois-based private equity firm that owns Aspen.
Aspen sells a wide variety of medical products including surgical needles and skin markers, disposable light handles, instrument guards, anti-fog products and fluid management products. Its brands include Richard-Allan, Dr. Fog, Sterion, Colby, Steriseal and Oxboro.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
As part of the deal, Aspen picks up a factory in Puerto Rico that manufactures Bard-Parker’s scalpels and blades.
RoundTable has been aggressive about funding Aspen’s growth through acquisitions since it bought the firm four years ago. The Bard-Parker purchase marks Aspen’s sixth acquisition in that time, according to the statement.
Other RoundTable portfolio companies include dermatology drugmaker Aqua Pharmaceuticals and Argon Medical Devices, which develops vascular-access and patient-monitoring devices. RoundTable manages about $1.9 billion in capital, according to the statement.
